The DOI matches its Crossref record.
Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- Arbiser, 2001, Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations, Am J Clin Pathol, 116, 473, 10.1309/425H-NW4W-XC9A-005H · DOI
- Ray-Coquard, 2012, Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions, Ann Oncol, 23, 2442, 10.1093/annonc/mdr610 · DOI · Paper page
- Thway, 2009, Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre, Sarcoma, 2009, 741975, 10.1155/2009/741975 · DOI
- Delattre, 1994, The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts, N Engl J Med, 331, 294, 10.1056/NEJM199408043310503 · DOI · Paper page
- Coindre, 2003, Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases, Cancer, 98, 2700, 10.1002/cncr.11840 · doi:10.1002/cncr.11840
- Guillou, 2001, Hum Pathol, 32, 105, 10.1053/hupa.2001.21130 · doi:10.1053/hupa.2001.21130
- Hostein, 2004, Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens, Cancer, 101, 2817, 10.1002/cncr.20711 · DOI
- Williamson, 2010, Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma, J Clin Oncol, 28, 2151, 10.1200/JCO.2009.26.3814 · DOI · Paper page
- Coindre, 2006, Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group, Cancer, 107, 1055, 10.1002/cncr.22099 · doi:10.1002/cncr.22099
- de Vreeze, 2010, Added value of molecular biological analysis in diagnosis and clinical management of liposarcoma: a 30-year single-institution experience, Ann Surg Oncol, 17, 686, 10.1245/s10434-009-0806-9 · doi:10.1245/s10434-009-0806-9
- Sirvent, 2007, Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR, Am J Surg Pathol, 31, 1476, 10.1097/PAS.0b013e3180581fff · DOI · Paper page
- Weaver, 2008, Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms, Mod Pathol, 21, 943, 10.1038/modpathol.2008.84 · DOI · Paper page
- Neuville, 2013, Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study, Am J Surg Pathol, 37, 1259, 10.1097/PAS.0b013e31828f51b9 · DOI
- Karanian, 2015, Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans, Mod Pathol, 28, 230, 10.1038/modpathol.2014.97 · doi:10.1038/modpathol.2014.97
- 2014, Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 25, iii102
- Blay, 2015, Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Oncol, 16, 531, 10.1016/S1470-2045(15)70102-6 · doi:10.1016/s1470-2045(15)70102-6
- von Mehren, 2014, Soft tissue sarcoma, version 2. 2014, J Natl Compr Canc Netw, 12, 473, 10.6004/jnccn.2014.0053 · DOI
- Kroep, 2011, First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study, Ann Oncol, 22, 207, 10.1093/annonc/mdq338 · doi:10.1093/annonc/mdq338
- Coindre, 2004, Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity, J Pathol, 203, 822, 10.1002/path.1579 · DOI
- Le Guellec, 2014, Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?, Am J Surg Pathol, 38, 293, 10.1097/PAS.0000000000000131 · doi:10.1097/pas.0000000000000131
- Italiano, 2008, HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon, Int J Cancer, 122, 2233, 10.1002/ijc.23380 · DOI · Paper page
- Ficher, 2014, The diversity of soft tissue tumours with EWSR1 gene rearrangements: a review, Histopathology, 64, 134, 10.1111/his.12269 · DOI · Paper page
- Antonescu, 2014, Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours, Pathology, 46, 105, 10.1097/PAT.0000000000000049 · DOI
- Argani, 2001, Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents, Am J Pathol, 159, 179, 10.1016/S0002-9440(10)61684-7 · DOI · Paper page
- Laé, 2009, Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum, Mod Pathol, 22, 291, 10.1038/modpathol.2008.184 · doi:10.1038/modpathol.2008.184
- Patel, 2015, Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology, Oncotarget, 6, 32602, 10.18632/oncotarget.5289 · DOI
- Italiano, 2007, Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the “missing link” between lipomas and liposarcomas?, Int J Cancer, 121, 308, 10.1002/ijc.22685 · doi:10.1002/ijc.22685
Cited by
Sarcoma classification by DNA methylation profiling
Koelsche, C., Schrimpf, D., Stichel, D., Sill, M., Sahm, F., Reuss, D. E., Blattner, M., Worst, B., Heilig, C. E., Beck, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20603-4 · Cited by 532
Transcriptomic definition of molecular subgroups of small round cell sarcomas
Watson, S., Perrin, V., Guillemot, D., Reynaud, S., Coindre, J., Karanian, M., Guinebretière, J., Freneaux, P., Le Loarer, F., Bouvet, M., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5053 · Cited by 335
Self-citationSarcoma treatment in the era of molecular medicine
Grünewald, T. G., Alonso, M., Avnet, S., Banito, A., Burdach, S., Cidre‐Aranaz, F., Di Pompo, G., Distel, M., Dorado‐Garcia, H., Garcia‐Castro, J., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911131 · Cited by 319
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081685 · Cited by 271
Sarcoma care in the era of precision medicine
Wallander, K., Öfverholm, I., Boye, K., Tsagkozis, P., Papakonstantinou, A., Lin, Y., & Haglund de Flon, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13717 · Cited by 30
Metadata
- Authors
- Italiano, A., Di Mauro, I., Rapp, J., Pierron, G., Auger, N., Alberti, L., Chibon, F., Escande, F., Voegeli, A.-C., Ghnassia, J.-P., Keslair, F., Laé, M., Ranchère-Vince, D., Terrier, P., Baffert, S., Coindre, J.-M., & Pedeutour, F.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 17
- Issue
- 4
- Pages
- 532-538
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W2295993263
- Cited by
- 191
- References
- 0
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Institut National Du Cancer
- Centre Hospitalier Universitaire de Nice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. https://app.cochat.ai/papers/10.1016/s1470-2045(15)00583-5
- The paper
- Italiano, A., Di Mauro, I., Rapp, J., Pierron, G., Auger, N., Alberti, L., Chibon, F., Escande, F., Voegeli, A.-C., Ghnassia, J.-P., Keslair, F., Laé, M., Ranchère-Vince, D., Terrier, P., Baffert, S., Coindre, J.-M., & Pedeutour, F. (2016). Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(15)00583-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.